Target intelligence / Profile preview

Interferon alpha-10 (IFNA10)

Target
IFNA10
Molecular classification
Cytokine, Type I interferon family
01

Overview

Interferon alpha-10 is a secreted cytokine encoded by the IFNA10 gene, a member of the type I interferon family[1][5]. It is produced mainly by macrophages and plasmacytoid dendritic cells in response to viral infection or pathogen-associated signals[1][2]. IFNA10 is among the strongest inducers of antiviral interferon-stimulated genes, exerting potent antiviral, immunomodulatory, and anti-proliferative effects via the JAK/STAT signaling pathway through IFNAR1/IFNAR2[2][6]. It plays key roles in host defense against viral infections, and dysregulated signaling has been implicated in diseases such as systemic lupus erythematosus, inflammatory disorders, and certain cancers[2]. IFNA10 can be modulated by drugs that block its receptor signaling, and altered levels of IFNA10 or downstream ISGs can serve as biomarkers of pathway activation and therapeutic response[2][1].

Other names
Interferon alpha-10IFNA10IFN-alpha-10LeIF CIFN-alphaCInterferon alpha-6LInterferon alpha-CleIF C
02

Mechanism of action

Agonist at type I interferon receptor (IFNAR1/IFNAR2), leading to JAK/STAT pathway activation and ISG induction; antagonist antibodies (e.g., Anifrolumab) block IFNAR1 preventing signaling

03

Biological functions

Immune responseAntiviral activitySignal transductionInduction of interferon-stimulated genes (ISGs)ImmunomodulationAnti-proliferative activity
04

Disease associations

InfectionInflammationAutoimmune diseaseCancer
05

Safety considerations

Risk of immune-mediated adverse effects (such as autoimmunity and inflammation)cytokine release syndromeoff-target immune activation
06

Interacting drugs

Anifrolumab (targets IFNAR1, a component of the receptor for IFNA10)
07

Biomarkers

ISG expression (e.g., IFIT1, CXCL10, ISG15) for pathway activationelevated IFNA10 in autoimmune conditions (e.g., SLE)

Beyond the preview

Go deeper on Interferon alpha-10 (IFNA10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interferon alpha-10 (IFNA10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call